BAMIPINE HYDROCHLORIDE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H24N2.ClH
Molecular Weight	316.868
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.CN1CCC(CC1)N(CC2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=OIKFTEUNPYSIGY-UHFFFAOYSA-N

InChI=1S/C19H24N2.ClH/c1-20-14-12-19(13-15-20)21(18-10-6-3-7-11-18)16-17-8-4-2-5-9-17;/h2-11,19H,12-16H2,1H3;1H

HIDE SMILES / InChI

Molecular Formula	C19H24N2
Molecular Weight	280.4073
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.drugs.com/international/bamipine.html | http://en.pharmacodia.com/web/drug/1_12084.html

Bamipine (trade name Soventol) is a sedating antihistamine with pronounced sedative effects. Bamipine is a pharmaceutical drug acting as an H1 antihistamine with anticholinergic properties. It is used as an antipruritic ointment. Bamipine hydrochloride has been given by mouth. Bamipine, bamipine lactate, and bamipine salicylate have all been applied topically.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Histamine H1 receptor 315 Target ID: CHEMBL3943 Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D07197 \| https://www.ncbi.nlm.nih.gov/pubmed/18977145	Antagonist 2778

Conditions

Condition	Modality	Targets	Highest Phase	Product
Allergy 44 Sources: http://www.ndrugs.com/?s=bamipine http://www.druginfosys.com/drug.aspx?drugcode=1567&type=1	Primary		Approved 8429	Soventol Approved Use Allergic conditions

PubMed

Title	Date	PubMed
Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.	2007 Dec 1	17826096
Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives.	2008 Dec 15	18977145

Patents

Sample Use Guides

In Vivo Use Guide

The recommended dose is 50-100 mg 3-4 times/day.

Route of Administration: Oral

In Vitro Use Guide

Bamipine treatment resulted in 29% of inhibition of Mycobacterium tuberculosis H37Rv (after 4 days by microplate alamar blue assay) at 6.25 ug/mL.

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:59:09 GMT 2023` Edited by `admin` on `Fri Dec 15 16:59:09 GMT 2023`
Record UNII	4K9380352I
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BAMIPINE HYDROCHLORIDE

Common Name

English

Bamipine hydrochloride [WHO-DD]

Common Name

English

4-PIPERIDINAMINE, 1-METHYL-N-PHENYL-N-(PHENYLMETHYL)-, HYDROCHLORIDE (1:1)

Systematic Name

English

4-PIPERIDINAMINE, 1-METHYL-N-PHENYL-N-(PHENYLMETHYL)-, MONOHYDROCHLORIDE

Common Name

English

BAMIPINE HYDROCHLORIDE [MI]

Common Name

English

BAMIPINE MONOHYDROCHLORIDE

Common Name

English

SOVENTOL

Brand Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29578